{"content":"<li class=\"n-box-item date-title\" data-end=\"1411790399\" data-start=\"1411704000\" data-txt=\"Saturday, December 21, 2019\">Friday, September 26, 2014</li><li class=\"n-box-item sa-box-item\" data-id=\"2003515\" data-ts=\"1411772686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003515-ambarella-rallies-following-bullish-gopro-checks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella rallies following bullish GoPro checks</a></h4><ul>\n<li>JPMorgan's Paul Coster <a href=\"http://www.streetinsider.com/Analyst+Comments/GoPro+%28GPRO%29+PT+Lifted+at+JPMorgan%2C+But+Remains+34%25+Below+Market%3B+Short+Squeeze+Driving+Stock/9863358.html\" target=\"_blank\">reports</a> GoPro (<a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a> <font color=\"green\">+1%</font>) channel checks revealed \"intra-quarter stock-outs in both the big-box and specialty channels.\" That has led him to raise his Q3 GoPro sales forecast to the high end of the company's guidance range.</li>\n<li>Coster maintains a Neutral rating on GoPro - he downgraded on account of valuation <a href=\"https://seekingalpha.com/news/1958625-gopro-squeezes-higher-on-strong-volume\" target=\"_blank\">last month</a> - but nonetheless argues \"the firm\u2019s growth prospects are very good, tilted to the upside relative to sell-side expectations.\" Coster also notes 40% of the float remains shorted, possibly driving a fresh squeeze.</li>\n<li>Video processor supplier Ambarella (<a href=\"https://seekingalpha.com/symbol/AMBA\" title=\"Ambarella\">AMBA</a> <font color=\"green\">+5.2%</font>) rallied strongly today. Shares set a new high of $42.77 on Tuesday before selling off.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1969995-ambarella-pares-gains-in-spite-of-bullish-notes-gopro-up-sharply\" target=\"_blank\">Previous:</a> GoPro up sharply following Ambarella's earnings</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2003515\" data-linked=\"Ambarella rallies following bullish GoPro checks\" data-tweet=\"$GPRO $GPRO $AMBA - Ambarella rallies following bullish GoPro checks https://seekingalpha.com/news/2003515-ambarella-rallies-following-bullish-gopro-checks?source=tweet\" data-url=\"https://seekingalpha.com/news/2003515-ambarella-rallies-following-bullish-gopro-checks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003435\" data-ts=\"1411767430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003435-after-hour-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hour Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/ALIM' title='Alimera Sciences, Inc.'>ALIM</a> <font color='green'>+18.8%</font>. PSDV <font color='green'>+10.3%</font>. <a href='https://seekingalpha.com/symbol/TVPT' title='Travelport'>TVPT</a> <font color='green'>+3.3%</font>. <a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a> <font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/LAS' title='Lentuo International Inc.'>LAS</a> <font color='green'>+2.8%</font>.</li><li><b>Top losers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='red'>-2.8%</font>. <a href='https://seekingalpha.com/symbol/CZZ' title='Cosan Limited'>CZZ</a> <font color='red'>-2.7%</font>. TQNT <font color='red'>-2.6%</font>. CISG <font color='red'>-2.3%</font>. <a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='red'>-1.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2003435\" data-linked=\"After Hour Gainers / Losers\" data-tweet=\"$ALIM $EYPT $TVPT - After Hour Gainers / Losers https://seekingalpha.com/news/2003435-after-hour-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2003435-after-hour-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003415\" data-ts=\"1411765250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003415-micron-nears-34-as-dram-pricing-applauded-sandisk-tops-99\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron nears $34 as DRAM pricing applauded; SanDisk tops $99</a></h4><ul>\n<li>Several firms have hiked their Micron (<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"green\">+6.8%</font>) targets following the memory <a href=\"https://seekingalpha.com/news/2001845-micron-now-plus-4-percent-ah-post-earnings-sandisk-plus-0_6-percent\" target=\"_blank\">giant's FQ4 beat</a> and above-consensus <a href=\"https://seekingalpha.com/news/2001925-micron-guides-strong-dram-and-nand-growth-to-pick-up\" target=\"_blank\">FQ1 guidance</a>. Shares closed about a dollar below a July high of $34.85.</li>\n<li>Jefferies' <a href=\"http://blogs.barrons.com/techtraderdaily/2014/09/26/micron-jumps-7-bulls-urge-closet-bears-to-give-up-already/\" target=\"_blank\">Sundeep Bajikar</a> (PT hiked to $42) says the numbers are \"likely to increase the probability of ~$4 EPS power in investors\u2019 minds, and help closet bears embrace permanent DRAM industry changes with less fear.\" He forecasts $3.4B in FY15 (ends Aug. '15) free cash flow, up from $2.6B in FY14.</li>\n<li>Drexel Hamilton's Rick Whittington takes Micron's performance as proof the company has sidestepped Samsung's <a href=\"https://seekingalpha.com/news/1888605-micron-tumbles-following-samsungs-results-dram-forecast\" target=\"_blank\">DRAM capacity hike</a>. \"Samsung\u2019s DRAM output shock last month appears absorbed as computing upsides have accounted for the increased bits\u201d \u2014 and it is set to benefit from rising complexity of DRAM production.\"</li>\n<li>Nomura's Romit Shah observes guidance for low-single digit DRAM ASP growth is much better than his prior forecast for a 4% drop. <a href=\"http://247wallst.com/technology-3/2014/09/26/analysts-view-micron-even-higher-after-earnings-targets-and-calls/\" target=\"_blank\">BofA/Merrill reports </a>(citing talks with management) some OEMs \"want to purchase DRAM at a fixed price (no cuts) for the entirety of 4Q14 due to shortage concerns.\"</li>\n<li>On the CC (<a href=\"https://seekingalpha.com/article/2522215-micron-technologys-mu-ceo-mark-durcan-on-q4-2014-results-earnings-call-transcript\" target=\"_blank\">transcript</a>), Micron forecast 2015 DRAM industry bit supply growth will be in a low-to-mid 20% range, down from a 2014 level of ~30%. Moreover, high-teens to low-20s growth is expected in later years, as restrained capex keeps a lid on output.</li>\n<li>Industry NAND output is expected to grow at a high-30s to mid-40s clip in 2015, following high-30s to low-40s growth in 2014. 3D NAND investments and interest in addressing strong mobile/SSD demand is fueling the growth.</li>\n<li>SanDisk (SNDK <font color=\"green\">+2.3%</font>) followed Micron higher.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2003415\" data-linked=\"Micron nears $34 as DRAM pricing applauded; SanDisk tops $99\" data-tweet=\"$MU $MU $WDC - Micron nears $34 as DRAM pricing applauded; SanDisk tops $99 https://seekingalpha.com/news/2003415-micron-nears-34-as-dram-pricing-applauded-sandisk-tops-99?source=tweet\" data-url=\"https://seekingalpha.com/news/2003415-micron-nears-34-as-dram-pricing-applauded-sandisk-tops-99\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003325\" data-ts=\"1411763439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALIM\" target=\"_blank\">ALIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003325-fda-clears-iluvien\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Iluvien</a></h4><ul>\n<li>\n<a href=\"http://www.businesswire.com/news/home/20140926005490/en/pSivida-Corp.-Reports-FDA-Approval-ILUVIEN%C2%AE-Diabetic#.VCXLQfldXGA\" target=\"_blank\">The FDA approves</a> Alimera Sciences' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ALIM\" title=\"Alimera Sciences, Inc.\">ALIM</a>) NDA for <a href=\"http://www.psivida.com/products-iluvien.html\" target=\"_blank\">Iluvien </a>(fluocinolone acetonide intravitreal implant) for the treatment of patients with diabetic macular edema (DME) who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure. A single injection of the Iluvien micro-insert provides sustained treatment for DME for 36 months.</li>\n<li>Iluvien's regulatory clearance triggers a $25M milestone payment to pSivida (PSDV) from licensee Alimera.</li>\n<li>Alimera intends to <a href=\"http://www.sec.gov/Archives/edgar/data/1267602/000126760214000061/pressrelease.htm\" target=\"_blank\">launch </a>the product in the U.S. in Q1.</li>\n<li>Iluvien is already commercially available in the UK and Germany.</li>\n<li>ALIM up <font color=\"green\">28%</font> AH on high volume. PSDV up <font color=\"green\">15%</font> AH also on high volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2003325\" data-linked=\"FDA clears Iluvien\" data-tweet=\"$ALIM $ALIM $EYPT - FDA clears Iluvien https://seekingalpha.com/news/2003325-fda-clears-iluvien?source=tweet\" data-url=\"https://seekingalpha.com/news/2003325-fda-clears-iluvien\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003315\" data-ts=\"1411763123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003315-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/vxx' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='green'>+7.6%</font>. <a href='https://seekingalpha.com/symbol/gaz' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color='green'>+3.32%</font>. <a href='https://seekingalpha.com/symbol/ung' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='green'>+3.01%</font>. <a href='https://seekingalpha.com/symbol/oil' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='green'>+1.95%</font>. <a href='https://seekingalpha.com/symbol/uso' title='The United States Oil ETF, LP'>USO</a> <font color='green'>+1.73%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ura' title='Global X Uranium ETF'>URA</a> <font color='red'>-7.09%</font>. <a href='https://seekingalpha.com/symbol/fcg' title='First Trust ISE-Revere Natural Gas Index ETF'>FCG</a> <font color='red'>-5.59%</font>. <a href='https://seekingalpha.com/symbol/kol' title='Market Vectors Coal ETF'>KOL</a> <font color='red'>-4.48%</font>. <a href='https://seekingalpha.com/symbol/dem' title='WisdomTree Emerging Markets Equity Income ETF'>DEM</a> <font color='red'>-4.38%</font>. <a href='https://seekingalpha.com/symbol/gdxj' title='Market Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='red'>-4.27%</font>.</li></ul>  &nbsp;  &nbsp;<div class=\"tiny-share-widget\" data-id=\"2003315\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$VXX $GAZ-OLD $UNG - Weekly ETF Gainers / Losers https://seekingalpha.com/news/2003315-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2003315-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003225\" data-ts=\"1411760913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALIM\" target=\"_blank\">ALIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003225-iluvien-nda-news-pending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iluvien NDA news pending</a></h4><ul><li>NASDAQ halts trading in Alimera Sciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ALIM\" title=\"Alimera Sciences, Inc.\">ALIM</a>) and pSivida (PSDV) pending news. Today is the<a href=\"https://seekingalpha.com/news/1987815-pdufa-date-approaches-for-iluvien\" target=\"_blank\"> PDUFA date</a> for Alimera's resubmitted NDA for <a href=\"http://www.psivida.com/products-iluvien.html\" target=\"_blank\">Iluvien </a>(190 mcg fluocinolone acetonide intravitreal implant in applicator).</li></ul><div class=\"tiny-share-widget\" data-id=\"2003225\" data-linked=\"Iluvien NDA news pending\" data-tweet=\"$ALIM $ALIM $EYPT - Iluvien NDA news pending https://seekingalpha.com/news/2003225-iluvien-nda-news-pending?source=tweet\" data-url=\"https://seekingalpha.com/news/2003225-iluvien-nda-news-pending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003215\" data-ts=\"1411760629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTSL\" target=\"_blank\">WTSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003215-wet-seal-plus-5-percent-after-re-hiring-former-digital-chief\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wet Seal +5% after re-hiring former digital chief</a></h4><ul>     <li>Wet Seal (<a href=\"https://seekingalpha.com/symbol/WTSL\" title=\"The Wet Seal, Inc.\">WTSL</a> <font color=\"green\">+5%</font>) is on the move on news that Jon Kubo is returning to the teen retailer, this time filling the newly created position of chief digital officer, effective Oct. 6.</li>\n<li>Kubo will oversee e-commerce, digital marketing and the IT organization to integrate digital consumer experiences throughout the business.</li>\n<li>He previously worked for WTSL during 2005-2011 as chief information officer and the head of its e-commerce operations.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2003215\" data-linked=\"Wet Seal +5% after re-hiring former digital chief\" data-tweet=\"$WTSL - Wet Seal +5% after re-hiring former digital chief https://seekingalpha.com/news/2003215-wet-seal-plus-5-percent-after-re-hiring-former-digital-chief?source=tweet\" data-url=\"https://seekingalpha.com/news/2003215-wet-seal-plus-5-percent-after-re-hiring-former-digital-chief\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003195\" data-ts=\"1411759673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOC\" target=\"_blank\">NOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003195-northrop-raised-to-buy-at-deutsche-bank-as-defense-spending-bottoms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northrop raised to Buy at Deutsche Bank as defense spending bottoms</a></h4><ul>     <li>Northrop Grumman (<a href=\"https://seekingalpha.com/symbol/NOC\" title=\"Northrop Grumman Corporation\">NOC</a> <font color=\"green\">+2.4%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/14/09/4879075/update-deutsche-bank-upgrades-northrop-grumman-corporati\" target=\"_blank\">upgraded to Buy</a> from Hold with a $145 price target at Deutsche Bank, which sees the down cycle in defense spending fading and the possibility of budget increases into FY 2017.</li>\n<li>The firm feels defense spending is bottoming as global tensions rise  along with a shift in public sentiment on threats and priorities, and a turn in defense spending would benefit NOC more than its peers since 86% of the company's sales are tied to the U.S. government.</li>\n<li>DB also likes that NOC returns 100% of free cash flow to its shareholders; NOC increased its dividend by 15% in May, has bought back 17M  million shares YTD, has retired 30M shares and plans to retire 30M more shares by year-end 2015.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2003195\" data-linked=\"Northrop raised to Buy at Deutsche Bank as defense spending bottoms\" data-tweet=\"$NOC - Northrop raised to Buy at Deutsche Bank as defense spending bottoms https://seekingalpha.com/news/2003195-northrop-raised-to-buy-at-deutsche-bank-as-defense-spending-bottoms?source=tweet\" data-url=\"https://seekingalpha.com/news/2003195-northrop-raised-to-buy-at-deutsche-bank-as-defense-spending-bottoms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003085\" data-ts=\"1411753576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003085-virnetx-crossroads-document-security-post-big-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX, Crossroads, Document Security post big gains</a></h4><ul>\n<li>Patent licensing firms VirnetX (<a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a> <font color=\"green\">+15.2%</font>), Crossroads (<a href=\"https://seekingalpha.com/symbol/CRDS\" title=\"Crossroads Systems, Inc.\">CRDS</a> <font color=\"green\">+12.8%</font>), and Document Security (<a href=\"https://seekingalpha.com/symbol/DSS\" title=\"Document Security Systems, Inc\">DSS</a> <font color=\"green\">+9.4%</font>) are among the day's biggest gainers. Shares of all three companies <a href=\"https://www.google.com/finance?chdnp=1&amp;chfdeh=0&amp;chdet=1411761600000&amp;chddm=6803&amp;cmpto=NYSEMKT:VHC;NASDAQ:CRDS;NYSEMKT:DSS&amp;cmptdms=0;0;0&amp;q=vhc,crds,\" target=\"_blank\">had fallen hard</a> in recent weeks (<a href=\"https://seekingalpha.com/news/1989915-virnetx-continues-cratering-following-apple-ruling\" target=\"_blank\">VirnetX especially</a>).</li>\n<li>End-of-quarter short-covering could be contributing to VrinetX and Document Security's gains: The companies respectively had 17.7M and 2.3M shares shorted as of Sep. 15. Crossroads only had 240K shares shorted.</li>\n<li>Earlier this week, <a href=\"http://online.wsj.com/articles/federal-courts-reject-more-software-patents-after-supreme-court-ruling-1411343300\" target=\"_blank\">the <em>WSJ</em> observed</a> federal courts have increasingly been making adverse rulings on software patents since June's <a href=\"https://seekingalpha.com/news/1809183-supreme-court-upholds-software-patents-but-sets-limits\" target=\"_blank\">Supreme Court ruling</a>. \"This is only the beginning of the fallout,\" Stanford law prof. Mark Lemley is quoted as saying.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2003085\" data-linked=\"VirnetX, Crossroads, Document Security post big gains\" data-tweet=\"$VHC $VHC $CRDS - VirnetX, Crossroads, Document Security post big gains https://seekingalpha.com/news/2003085-virnetx-crossroads-document-security-post-big-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/2003085-virnetx-crossroads-document-security-post-big-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003075\" data-ts=\"1411751702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNET\" target=\"_blank\">CNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003075-chinanet-plus-28_9-percent-after-mentioning-alibaba-support\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChinaNet +28.9% after mentioning Alibaba support</a></h4><ul>\n<li>A ChinaNet (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CNET\" title=\"ChinaNet Online Holdings, Inc.\">CNET</a>) presentation (<a href=\"http://www.sec.gov/Archives/edgar/data/1376321/000117184314004490/exh_991.htm\" target=\"_blank\">provided</a> in an 8-K filing) notes the company's Micro-Sell 360 mobile commerce marketing platform supports Alibaba's massive Taobao site. Amazon support is also mentioned.</li>\n<li>ChinaNet soared last week after stating it's \"in discussions with Taobao\" to provide Micro-Sell 360 support, and that its new partnership with Baidu has yielded \"an improved sell-through on digital advertising products.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2003075\" data-linked=\"ChinaNet +28.9% after mentioning Alibaba support\" data-tweet=\"$CNET - ChinaNet +28.9% after mentioning Alibaba support https://seekingalpha.com/news/2003075-chinanet-plus-28_9-percent-after-mentioning-alibaba-support?source=tweet\" data-url=\"https://seekingalpha.com/news/2003075-chinanet-plus-28_9-percent-after-mentioning-alibaba-support\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003065\" data-ts=\"1411751559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGIO\" target=\"_blank\">AGIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003065-agios-hits-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agios hits new high</a></h4><ul>\n<li>Moderately-traded biotech Angios Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/AGIO\" title=\"Agios Pharmaceuticals, Inc.\">AGIO</a> <font color=\"green\">+19.6%</font>) jumps on a 10x surge in volume. Shares have quadrupled since the low of $15.77 on November 18, 2013.</li>\n<li>In November, the company will present clinical data from a Phase 1 trial of AG-120, an orally available inhibitor of the mutated <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23558169\" target=\"_blank\">IDH1 protein</a>, being developed to treat hematologic malignancies and solid tumors.</li>\n<li>Collaboration partner Celgene (<a href=\"https://seekingalpha.com/symbol/CELG\" title=\"Celgene Corporation\">CELG</a> <font color=\"green\">+0.3%</font>) has a 15% stake in the company.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2003065\" data-linked=\"Agios hits new high\" data-tweet=\"$AGIO $AGIO $CELG - Agios hits new high https://seekingalpha.com/news/2003065-agios-hits-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/2003065-agios-hits-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003005\" data-ts=\"1411750194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003005-tonix-up-on-plans-to-report-bestfit-trial-results-by-october-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix up on plans to report BESTFIT trial results by October 15</a></h4><ul>\n<li>Thinly-traded nano cap Tonix Phamaceuticals (<a href=\"https://seekingalpha.com/symbol/TNXP\" title=\"Tonix Pharmaceuticals Holding Corp.\">TNXP</a> <font color=\"green\">+12.3%</font>) jumps on higher-than-average volume in response to the company's disclosure in an <a href=\"http://www.sec.gov/Archives/edgar/data/1430306/000114420414057964/v390105_ex99-01.htm\" target=\"_blank\">investor presentation</a> that it plans to report top-line results from its BESTFIT Phase 2b/3 <a href=\"http://clinicaltrials.gov/show/NCT01903265\" target=\"_blank\">clinical trial</a> evaluating the safety and efficacy of <a href=\"http://www.tonixpharma.com/pipeline/tnx-102-sl-for-fibromyalgia\" target=\"_blank\">TNX-102 SL</a> for the treatment of adult patients with <a href=\"http://en.wikipedia.org/wiki/Fibromyalgia\" target=\"_blank\">fibromyalgia </a>by October 15, 2014.</li>\n<li>In the Phase 2a trial, patients treated with TNX-102 capsules experienced average pain reduction of 26% versus placebo and over 70% of patients reported an improvement in sleep quality compared to placebo.</li>\n<li>Tonix estimates market clearance in 2017.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2003005\" data-linked=\"Tonix up on plans to report BESTFIT trial results by October 15\" data-tweet=\"$TNXP - Tonix up on plans to report BESTFIT trial results by October 15 https://seekingalpha.com/news/2003005-tonix-up-on-plans-to-report-bestfit-trial-results-by-october-15?source=tweet\" data-url=\"https://seekingalpha.com/news/2003005-tonix-up-on-plans-to-report-bestfit-trial-results-by-october-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003025\" data-ts=\"1411749939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003025-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/JNS\" title=\"Janus Capital Group Inc.\">JNS</a> <font color=\"green\">+34%</font>. <a href=\"https://seekingalpha.com/symbol/DGLY\" title=\"Digital Ally, Inc.\">DGLY</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/CNET\" title=\"ChinaNet Online Holdings, Inc.\">CNET</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/SSY\" title=\"SunLink Health Systems, Inc\">SSY</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/AGIO\" title=\"Agios Pharmaceuticals, Inc.\">AGIO</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/CRRS\" title=\"Corporate Resource Services, Inc.\">OTC:CRRS</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/NAII\" title=\"Natural Alternatives International, Inc.\">NAII</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/OVAS-OLD\" title=\"OvaScience, Inc.\">OVAS-OLD</a> <font color=\"green\">+15%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/PULS-OLD\" title=\"Pulse Electronics Corporation\">PULS-OLD</a> <font color=\"red\">-32%</font>. <a href=\"https://seekingalpha.com/symbol/ALCS\" title=\"ALCO Stores, Inc.\">ALCS</a> <font color=\"red\">-24%</font>. <a href=\"https://seekingalpha.com/symbol/ACRX\" title=\"AcelRx Pharmaceuticals, Inc.\">ACRX</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/RITT\" title=\"RiT Technologies Ltd.\">OTC:RITT</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/EAC\" title=\"Erickson Air-Crane\">EAC</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/FINL\" title=\"The Finish Line, Inc.\">FINL</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/GLYC\" title=\"GlycoMimetics\">GLYC</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/IRM\" title=\"Iron Mountain Inc.\">IRM</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/FSNN\" title=\"Fusion Connect, Inc.\">FSNN</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/POWL\" title=\"Powell Industries, Inc.\">POWL</a> <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2003025\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$JNS $DGLY $CNET - Midday Gainers / Losers https://seekingalpha.com/news/2003025-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2003025-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2003015\" data-ts=\"1411749672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIXXF\" target=\"_blank\">AIXXF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2003015-aixtron-continues-rally-following-ms-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aixtron continues rally following MS upgrade</a></h4><ul><li>Morgan Stanley has upgraded Aixtron (AIXG <font color='green'>+8.4%</font>) to Overweight a day after the company announced <a href=\"https://seekingalpha.com/news/2001115-aixtron-plus-14-percent-on-major-chinese-led-equipment-order\" target=\"_blank\">a major order</a> from Chinese LED manufacturer San'an Optoelectronics.</li><li>Shares are at their highest levels since May. <a href=\"https://twitter.com/thenotablecalls/status/515145246788026368\" target=\"_blank\">Commerzbank</a> thinks the San'an order could be worth $100M.</li></ul><div class=\"tiny-share-widget\" data-id=\"2003015\" data-linked=\"Aixtron continues rally following MS upgrade\" data-tweet=\"$AIXXF - Aixtron continues rally following MS upgrade https://seekingalpha.com/news/2003015-aixtron-continues-rally-following-ms-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2003015-aixtron-continues-rally-following-ms-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002985\" data-ts=\"1411748465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AABA\" target=\"_blank\">AABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002985-activist-starboard-takes-stake-in-yahoo-calls-for-aol-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activist Starboard takes stake in Yahoo, calls for AOL merger</a></h4><ul>\n<li>In an open letter, activist investor Starboard Value says it's \"a significant shareholder\" in Yahoo (YHOO <font color=\"green\">+3.9%</font>), and calls for the company to \"explore a strategic combination with AOL (<a href=\"https://seekingalpha.com/symbol/AOL\" title=\"AOL Inc.\">AOL</a> <font color=\"green\">+6.1%</font>).\"</li>\n<li>Starboard also wants Yahoo to \"[unlock] the substantial value\" in its Alibaba and Yahoo Japan stakes in a tax-efficient manner (could be easier said than done), cut losses in its display ad/content ops by $250M-$500M through cost cuts, and put an end to its \"aggressive\" M&amp;A strategy.</li>\n<li>The firm estimates a $17.67/share \"value gap\" exists between Yahoo's trading price and its sum-of-the-parts valuation, something it attributes to tax worries and concerns about how Yahoo will spend any Alibaba/Yahoo Japan proceeds (<a href=\"https://seekingalpha.com/news/1995475-yahoo-closes-below-39-as-tax-bill-investment-plans-mulled\" target=\"_blank\">previous</a>).</li>\n<li>It thinks an AOL deal \"could offer synergies of up to $1 billion by significantly reducing the cost overlaps in [Yahoo and AOL's] Display advertising businesses as well as synergies in corporate overhead.\" Starboard also believes an AOL merger could lower Yahoo's Alibaba/Yahoo Japan tax bill.</li>\n<li>Josh Brown <a href=\"https://seekingalpha.com/news/1993205-analysts-defend-alibabas-valuation-yahoo-an-activist-target\" target=\"_blank\">argued last week</a> Yahoo is now a prime target for activists. Starboard <a href=\"https://seekingalpha.com/news/367941\" target=\"_blank\">once waged</a> a failed proxy battle against AOL.</li>\n<li>Yahoo and AOL have both spiked in response to Starboard's letter.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002985\" data-linked=\"Activist Starboard takes stake in Yahoo, calls for AOL merger\" data-tweet=\"$AABA $AABA $AOL - Activist Starboard takes stake in Yahoo, calls for AOL merger https://seekingalpha.com/news/2002985-activist-starboard-takes-stake-in-yahoo-calls-for-aol-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/2002985-activist-starboard-takes-stake-in-yahoo-calls-for-aol-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002975\" data-ts=\"1411748383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KWK\" target=\"_blank\">KWK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002975-quicksilver-resources-appoints-strategic-alternatives-officer-shares-minus-22-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quicksilver Resources appoints strategic alternatives officer, shares -22%</a></h4><ul>     <li>Quicksilver Resources (<a href=\"https://seekingalpha.com/symbol/KWK\" title=\"Quicksilver Resources Inc.\">KWK</a> <font color=\"red\">-22.6%</font>) plunges after <a href=\"https://www.sec.gov/Archives/edgar/data/1060990/000106099014000130/kwk8-k20140925.htm\" target=\"_blank\">appointing</a> John Little from Deloitte as its Strategic Alternatives Officer to explore strategic and  tactical options including marketing assets and identifying JV partners.</li>\n<li>In lowering its stock price target to $1 from $4, Howard Weil says if a Horn River Basin deal was close, the arrangement would not be  necessary; with no HRB deal, capital raise or significant move in  natural gas prices, the firm believes it is hard to see upside in the stock (Briefing.com).</li> </ul><div class=\"tiny-share-widget\" data-id=\"2002975\" data-linked=\"Quicksilver Resources appoints strategic alternatives officer, shares -22%\" data-tweet=\"$KWK - Quicksilver Resources appoints strategic alternatives officer, shares -22% https://seekingalpha.com/news/2002975-quicksilver-resources-appoints-strategic-alternatives-officer-shares-minus-22-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/2002975-quicksilver-resources-appoints-strategic-alternatives-officer-shares-minus-22-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002945\" data-ts=\"1411747235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSH\" target=\"_blank\">RSH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002945-radioshack-higher-after-financing-option-opens-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RadioShack higher after financing option opens up</a></h4><ul>     <li>Shares of RadioShack (<a href='https://seekingalpha.com/symbol/RSH' title='RadioShack Corporation'>RSH</a> <font color='green'>+24.5%</font>) pop after Standard General said it would go back to the table with the retailer to discuss <a href=\"http://www.bloomberg.com/news/2014-09-26/radioshack-jumps-amid-signs-financing-talks-are-moving-forward.html\" target=\"_blank\">financing options</a>.</li>     <li>In a SEC filing, Standard General noted it's working to help RadioShack manage the holiday season given its dire cash position.</li> <li>Shares of RSH cleared the buck-a-share level before settling back a bit.</li> <li><a href=\"http://www.sec.gov/Archives/edgar/data/96289/000119312514354136/d796769dsc13d.htm\" target=\"_blank\">SEC Form 13D</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"2002945\" data-linked=\"RadioShack higher after financing option opens up\" data-tweet=\"$RSH - RadioShack higher after financing option opens up https://seekingalpha.com/news/2002945-radioshack-higher-after-financing-option-opens-up?source=tweet\" data-url=\"https://seekingalpha.com/news/2002945-radioshack-higher-after-financing-option-opens-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002965\" data-ts=\"1411747022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EAC\" target=\"_blank\">EAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002965-erickson-air-crane-cut-to-sell-at-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Erickson Air-Crane cut to Sell at Stifel</a></h4><ul>     <li>Erickson Air-Crane (<a href=\"https://seekingalpha.com/symbol/EAC\" title=\"Erickson Air-Crane\">EAC</a> <font color=\"red\">-10.7%</font>) is <a href=\"http://www.streetinsider.com/Downgrades/Stifel+Downgrades+Erickson+Air-Crane+%28EAC%29+to+Sell/9863092.html\" target=\"_blank\">downgraded to Sell</a> from Hold at Stifel on concerns about continued losses and high debt levels.</li>     <li>The firm cites risks of largely unpredictable quarterly revenue and significant seasonal variability, continued losses, potential charges from further goodwill impairment and aircraft support parts obsolescence, high debt levels, and management's resorting to sale-leaseback of aircraft to provide additional operating cash; if the facts follow this pattern, Stifel says EAC debtholders could step in and have a larger role in controlling the company.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2002965\" data-linked=\"Erickson Air-Crane cut to Sell at Stifel\" data-tweet=\"$EAC - Erickson Air-Crane cut to Sell at Stifel https://seekingalpha.com/news/2002965-erickson-air-crane-cut-to-sell-at-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/2002965-erickson-air-crane-cut-to-sell-at-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002935\" data-ts=\"1411746542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZSEY\" target=\"_blank\">AZSEY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002935-pimco-s-funds-take-a-pounding-following-bill-gross-exit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pimco\u2019s funds take a pounding following Bill Gross exit</a></h4><ul><li>Pimco's closed-end funds and ETFs are <a href=\"http://www.bloomberg.com/news/2014-09-26/pimco-s-mutual-funds-plunge-following-bill-gross-exit.html\" target=\"_blank\">plunging</a> in the wake of <a href=\"https://seekingalpha.com/news/2002475-janus-capital-plus-19-percent-after-firm-hires-pimcos-bill-gross\" target=\"_blank\">Bill Gross' exit</a> to Janus: <a href='https://seekingalpha.com/symbol/PHK' title='PIMCO High Income Fund'>PHK</a> <font color='red'>-8.7%</font>, <a href='https://seekingalpha.com/symbol/PGP' title='PIMCO Global StocksPLUS&Income Fund'>PGP</a> <font color='red'>-8.5%</font>, <a href='https://seekingalpha.com/symbol/PTY' title='PIMCO Corporate&Income Opportunity Fund'>PTY</a> <font color='red'>-6.2%</font>, <a href='https://seekingalpha.com/symbol/PCN' title='PIMCO Corporate&Income Strategy Fund'>PCN</a> <font color='red'>-4.2%</font>, <a href='https://seekingalpha.com/symbol/RCS' title='PIMCO Strategic Income Fund, Inc'>RCS</a> <font color='red'>-4.3%</font>, <a href='https://seekingalpha.com/symbol/PFL' title='PIMCO  Income Strategy Fund'>PFL</a> <font color='red'>-3.6%</font>, <a href='https://seekingalpha.com/symbol/PFN' title='Pimco Income Strategy Fund II'>PFN</a> <font color='red'>-2.7%</font>, <a href='https://seekingalpha.com/symbol/PKO' title='PIMCO Income Opportunity Fund'>PKO</a> <font color='red'>-2.5%</font>, <a href='https://seekingalpha.com/symbol/PDI' title='PIMCO Dynamic Income Fund'>PDI</a> <font color='red'>-2.2%</font>, <a href='https://seekingalpha.com/symbol/PCI' title='PIMCO Dynamic Credit Income Fund'>PCI</a> <font color='red'>-1.4%</font>, <a href='https://seekingalpha.com/symbol/BOND' title='PIMCO Total Return ETF'>BOND</a> <font color='red'>-0.2%</font>.</li><li>\"A lot of people bought into Pimco because of Bill Gross, who was the  face of the organization, and so they&rsquo;re shooting first and asking  questions later,&rdquo; says Motley Fool Asset Management CIO Bill Mann. \"Investing is a personal business,  and the market is saying it trusted Bill Gross.&rdquo;</li><li>Meanwhile, headlines indicate Dan Ivascyn, Pimco's (<a href='https://seekingalpha.com/symbol/AZSEY' title='Allianz SE ADR'>OTCPK:AZSEY</a>, <a href='https://seekingalpha.com/symbol/ALIZF' title='Allianz SE'>OTCPK:ALIZF</a>) deputy chief investment officer, <a href=\"http://www.cnbc.com/id/102036193\" target=\"_blank\">will succeed Gross</a> and take over portfolio management; WSJ had written earlier this week that Ivasycn already was <a href=\"http://blogs.wsj.com/totalreturn/2014/09/24/has-bill-gross-been-replaced-as-pimcos-most-popular-fund-manager/\" target=\"_blank\">growing in popularity</a> among Pimco investors, who had been putting more money into his fund even as they were pulling it from Gross&rsquo; fund.</li></ul><div class=\"tiny-share-widget\" data-id=\"2002935\" data-linked=\"Pimco\u2019s funds take a pounding following Bill Gross exit\" data-tweet=\"$AZSEY $PHK $PGP - Pimco\u2019s funds take a pounding following Bill Gross exit https://seekingalpha.com/news/2002935-pimco-s-funds-take-a-pounding-following-bill-gross-exit?source=tweet\" data-url=\"https://seekingalpha.com/news/2002935-pimco-s-funds-take-a-pounding-following-bill-gross-exit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002925\" data-ts=\"1411746483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002925-apple-higher-after-stifel-bmo-hike-iphone-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple higher after Stifel, BMO hike iPhone estimates</a></h4><ul>\n<li>Bendgate <a href=\"http://blogs.barrons.com/techtraderdaily/2014/09/26/apple-rising-stifel-bmo-raise-iphone-estimates-amidst-bendgate/\" target=\"_blank\">isn't a concern</a> for Stifel's Aaron Rakers: Citing \"continued strong demand data points\" for the iPhone 6 (<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a> <font color=\"green\">+1.4%</font>) and an expectation Chinese sales will start by year's end, he's raising respectively raising his FQ4 and FQ1 iPhone sales estimates by 1.8M and 6.7M to 39.6M and 65.3M, while reiterating a Buy.</li>\n<li>Rakers adds a stronger mix of iPhone 6/6 Plus sales could yield upside to his forecasts. He thinks the 6/6Plus could account for 60-70% of FQ1 iPhone sales, leading iPhone ASP to rise to $680 or higher. ASP was only at <a href=\"https://seekingalpha.com/news/1858595-apples-cc-ipad-sales-margins-m-and-a-cash-balances-discussed\" target=\"_blank\">$561 in FQ3</a>, and $596 in FQ2.</li>\n<li>The iPhone 6 carries unsubsidized U.S. prices of $649-$849, and the 6 Plus prices of $749-$949. Rakers notes Apple's decision to double the storage capacities of higher-capacity models could also provide an ASP lift.</li>\n<li>BMO's Keith Bachman (Outperform) has upped his FY15 (ends Sep. '15) iPhone sales estimate by 10.6M units to 189M. The hike comes even though Bachman \"[remains] unclear about Apple\u2019s ability to sell the iPhone 6 and 6 Plus in China, particularly in the December quarter.\" He's also setting an FY15 Apple Watch forecast of 12M units.</li>\n<li>Also: <a href=\"http://www.macrumors.com/2014/09/25/mac-mini-october-update/\" target=\"_blank\">MacRumors reports</a> Apple is prepping a refresh for the Mac Mini, which was last updated two years ago. The site thinks the refresh could arrive in October, along with new iPads and Mac OS X Yosemite.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/2001385-apple-minus-2_8-percent-as-bendgate-ios-8_01-get-more-publicity\" target=\"_blank\">Yesterday:</a> Apple falls as Bendgate, iOS 8.01 get more publicity</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002925\" data-linked=\"Apple higher after Stifel, BMO hike iPhone estimates\" data-tweet=\"$AAPL - Apple higher after Stifel, BMO hike iPhone estimates https://seekingalpha.com/news/2002925-apple-higher-after-stifel-bmo-hike-iphone-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/2002925-apple-higher-after-stifel-bmo-hike-iphone-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002915\" data-ts=\"1411746398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLYC\" target=\"_blank\">GLYC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002915-pfizer-delays-start-of-rivipansel-phase-3-glyc-shares-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pfizer delays start of rivipansel Phase 3, GLYC shares drop</a></h4><ul>\n<li>Shares of thinly-traded nano cap GlycoMimetics (<a href=\"https://seekingalpha.com/symbol/GLYC\" title=\"GlycoMimetics\">GLYC</a> <font color=\"red\">-5.5%</font>) are under pressure in response to Pfizer's (<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a> <font color=\"red\">-1.2%</font>) notification that it will significantly delay the start of its Phase 3 clinical trial of GMI-1070 (<a href=\"http://www.glycomimetics.com/programs-pipeline/gmi-1070/\" target=\"_blank\">rivipansel</a>) due to a manufacturing development issue impacting formulated drug supply. Pfizer says that it will advise GLYC on a more specific timeframe regarding the commencement of the trial after it identifies the cause of the problem and a remedy.</li>\n<li>GLYC expected the trial to start in Q4. Its exclusive license agreement with Pfizer was signed in October 2011. The initial indication will be a treatment for <a href=\"http://en.wikipedia.org/wiki/Vaso-occlusive_crisis\" target=\"_blank\">vaso-occlusive crisis</a> of sickle cell disease.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002915\" data-linked=\"Pfizer delays start of rivipansel Phase 3, GLYC shares drop\" data-tweet=\"$GLYC $GLYC $PFE - Pfizer delays start of rivipansel Phase 3, GLYC shares drop https://seekingalpha.com/news/2002915-pfizer-delays-start-of-rivipansel-phase-3-glyc-shares-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/2002915-pfizer-delays-start-of-rivipansel-phase-3-glyc-shares-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002895\" data-ts=\"1411744742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDN\" target=\"_blank\">IDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002895-intellicheck-plus-4_9-percent-on-on-247k-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intellicheck +4.9% on on $247K contract</a></h4><ul>\n<li>The Fort Irwin National Training Center has awarded Intellicheck (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/IDN\" title=\"Intellicheck Mobilisa, Inc.\">IDN</a>) a $247K contract to upgrade its existing Intellicheck <a href=\"http://www.icmobil.com/identity-solutions/military/defense-id/faq\" target=\"_blank\">Defense ID</a> system.</li>\n<li>The upgrade will include card readers and an IM3000 Visitor Vendor Center - the latter will allow the base to \"issue local access credentials to be scanned at the gate for positive identification of anyone visiting the facility.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1963185-intellicheck-soars-following-ceos-fox-business-appearance\" target=\"_blank\">Previous:</a> Intellicheck soars following CEO's Fox Business appearance</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002895\" data-linked=\"Intellicheck +4.9% on on $247K contract\" data-tweet=\"$IDN - Intellicheck +4.9% on on $247K contract https://seekingalpha.com/news/2002895-intellicheck-plus-4_9-percent-on-on-247k-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/2002895-intellicheck-plus-4_9-percent-on-on-247k-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002855\" data-ts=\"1411743065\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDRBF\" target=\"_blank\">BDRBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002855-bombardier-receives-firm-order-for-40-cseries-jets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bombardier receives firm order for 40 CSeries jets</a></h4><ul>     <li>Bombardier (<a href=\"https://seekingalpha.com/symbol/BDRBF\" title=\"Bombardier Inc.B\">OTCQX:BDRBF</a> <font color=\"green\">+4.4%</font>) says it received a <a href=\"http://www.reuters.com/article/2014/09/26/us-bombardier-cseries-idUSKCN0HL16N20140926\" target=\"_blank\">firm order for 40 of its new CSeries jets</a>, with options on another 10, from leasing company Macquarie AirFinance, bringing the plane maker\u2019s total firm orders for the new aircraft to 243.</li>     <li>The CSeries program has suffered repeated delays and ballooning costs; Bombardier resumed CSeries test flights on Sept. 7 after an on-ground engine fire halted them in May.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002855\" data-linked=\"Bombardier receives firm order for 40 CSeries jets\" data-tweet=\"$BDRBF $BOMBF - Bombardier receives firm order for 40 CSeries jets https://seekingalpha.com/news/2002855-bombardier-receives-firm-order-for-40-cseries-jets?source=tweet\" data-url=\"https://seekingalpha.com/news/2002855-bombardier-receives-firm-order-for-40-cseries-jets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002845\" data-ts=\"1411743051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002845-linkedin-plus-3_4-percent-on-cowen-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LinkedIn +3.4% on Cowen upgrade</a></h4><ul>\n<li>LinkedIn's (LNKD) Sales Navigator product will see its revenue rise to $1.9B in 2019 from a mere $273M in 2014, forecasts Cowen's John Blackledge, <a href=\"http://www.streetinsider.com/Analyst+Comments/Cowen+Upgrades+LinkedIn+%28LNKD%29+to+Outperform%3B+Sales+Navigator+is+Positive%2C+L-T+Catalyst/9862912.html\" target=\"_blank\">upgrading shares</a> to Outperform. His target has been raised by $58 to $253.</li>\n<li>Blackledge is a big fan of the Sales Navigator overhaul <a href=\"http://sales.linkedin.com/blog/the-social-selling-era-starts-now/\" target=\"_blank\">LinkedIn rolled out</a> in late July for both PCs and mobile. It included a separate (non-LinkedIn) login, lead recommendation by account, better CRM software integration, easier data discovery, and other features sought by sales pros.</li>\n<li>He notes data suggests social selling can provide a major boost to sales productivity, in part because it can eliminate cold-calling. Sales Navigator's subscriber count is expected to see a 59% CAGR from 2014-2019, eventually reaching 1.9M (3% global salesforce penetration).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002845\" data-linked=\"LinkedIn +3.4% on Cowen upgrade\" data-tweet=\"$MSFT - LinkedIn +3.4% on Cowen upgrade https://seekingalpha.com/news/2002845-linkedin-plus-3_4-percent-on-cowen-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2002845-linkedin-plus-3_4-percent-on-cowen-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002775\" data-ts=\"1411741086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002775-blackberry-now-plus-6_6-percent-chen-forecasts-doubling-of-software-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry now +6.6%; Chen forecasts doubling of software sales</a></h4><ul>\n<li>Down initially following its mixed FQ2 results, BlackBerry (BBRY) has quickly reversed course.</li>\n<li>Possibly helping: John Chen <a href=\"http://www.cnbc.com/id/102033744?__source=seekingalpha\" target=\"_blank\">has forecast</a> BlackBerry's software revenue (aided by the upcoming <a href=\"http://press.blackberry.com/press/2014/blackberry-introduces-bes12-as-the-new-foundation-for-enterprise.html\" target=\"_blank\">BES 12</a> launch, and perhaps also <a href=\"http://www.qnx.com/products/qnxcar/\" target=\"_blank\">QNX</a> and <a href=\"https://seekingalpha.com/news/1876405-blackberry-buying-german-security-tech-developer\" target=\"_blank\">Secusmart</a>), will double in FY16 from an expected FY15 level of $250M. Software/other sales were 8% of revenue in FQ2.</li>\n<li>Chen also states BlackBerry has <a href=\"http://www.bloomberg.com/news/2014-09-26/blackberry-sells-200-000-passport-phones-reaching-profit.html\" target=\"_blank\">sold 200K</a> Passport phones since the device's <a href=\"https://seekingalpha.com/news/1999285-blackberry-launches-passport-reviewers-criticize-design\" target=\"_blank\">Wednesday launch</a>. End-user phone sales were an estimated 2.4M during FQ2.</li>\n<li>RBC's Mark Sue (Market Perform) notes services revenue (-19% Q/Q to $421M) was below his $453M estimate, and <a href=\"http://blogs.barrons.com/techtraderdaily/2014/09/26/blackberry-rising-street-lauds-gross-margin-cash-conservation-services-a-concern/?mod=BOL_hp_blog_tt\" target=\"_blank\">thinks the number</a> is \"likely to sustain concerns about BlackBerry\u2019s declining subscriber base.\" However, phone shipments of 2.1M were above RBC's 1.65M forecast.</li>\n<li>Cowen's Tim Arcuri (Market Perform) calls BlackBerry's 47.5% gross margin \"solid,\" At the same time, he argues \"investor concerns are increasingly likely to key on how/when new technology and growth initiatives can/will arrest the Service decline and deliver a revenue inflection beyond Hardware.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/news/2002195-blackberry-beats-by-0_14-misses-on-revenue\" target=\"_blank\">FQ2 results</a>, <a href=\"https://seekingalpha.com/news/2002615-blackberry-minus-1_1-percent-street-balances-cost-cuts-services-decline\" target=\"_blank\">details</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002775\" data-linked=\"BlackBerry now +6.6%; Chen forecasts doubling of software sales\" data-tweet=\"$BB - BlackBerry now +6.6%; Chen forecasts doubling of software sales https://seekingalpha.com/news/2002775-blackberry-now-plus-6_6-percent-chen-forecasts-doubling-of-software-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/2002775-blackberry-now-plus-6_6-percent-chen-forecasts-doubling-of-software-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002745\" data-ts=\"1411740477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNS\" target=\"_blank\">JNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002745-treasurys-slip-on-concern-pimco-may-sour-on-u-s-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasurys slip on concern Pimco may sour on U.S. debt</a></h4><ul>     <li>It's not just shares of Janus (<a href=\"https://seekingalpha.com/symbol/JNS\" title=\"Janus Capital Group Inc.\">JNS</a> <font color=\"green\">+36.2%</font>) and Allianz (<a href=\"https://seekingalpha.com/symbol/AZSEY\" title=\"Allianz SE ADR\">OTCPK:AZSEY</a> <font color=\"red\">-5.7%</font>) that are moving in response to <a href=\"https://seekingalpha.com/news/2002475-janus-capital-plus-19-percent-after-firm-hires-pimcos-bill-gross\" target=\"_blank\">Bill Gross' job change</a> - traders say the news sparked <a href=\"http://blogs.wsj.com/moneybeat/2014/09/26/heres-the-bill-gross-effect-on-shares-an-index-and-bonds\" target=\"_blank\">knee-jerk selling in Treasury bonds</a>.</li>     <li>\"Concerns over his abrupt departure are weighing on Treasury prices,\" says Tom di Galoma, head of fixed income rates at ED&amp;F Man Capital Markets; <a href=\"http://online.wsj.com/articles/u-s-government-bonds-selling-off-on-news-of-gross-joining-janus-1411738072\" target=\"_blank\">the fear is that Pimco's clients will redeem</a>, forcing Pimco to liquidate Treasury bonds.</li>     <li>\u201cHe\u2019s been a bond bull for most of his career, and during that time bonds have been in a bull market - <a href=\"http://www.bloomberg.com//news/2014-09-26/treasuries-decline-on-concern-pimco-may-sour-on-u-s-debt.html\" target=\"_blank\">maybe the next Pimco bond managers won\u2019t be as bullish</a>,\u201d says Aaron Kohli of BNP Paribas.</li>     <li>Gross manages the $221B Pimco Total Return Fund, the world's largest bond fund by assets, which held 41% of its investments in U.S. government-related holdings, a proxy for Treasury bonds, at the end of August.</li>\n<li>Treasurys have climbed off lows but remain in the red: <a href=\"https://seekingalpha.com/symbol/TBT\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a>, <a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a>, <a href=\"https://seekingalpha.com/symbol/TMV\" title=\"Direxion Daily 20+ Year Treasury Bear 3x Shares ETF\">TMV</a>, <a href=\"https://seekingalpha.com/symbol/SHY\" title=\"iShares 1-3 Year Treasury Bond ETF\">SHY</a>, <a href=\"https://seekingalpha.com/symbol/IEF\" title=\"iShares 7-10 Year Treasury Bond ETF\">IEF</a>, <a href=\"https://seekingalpha.com/symbol/TBF\" title=\"ProShares Short 20+ Year Treasury ETF\">TBF</a>, <a href=\"https://seekingalpha.com/symbol/EDV\" title=\"Vanguard Extended Duration Treasury ETF\">EDV</a>, <a href=\"https://seekingalpha.com/symbol/PST\" title=\"ProShares UltraShort 7-10 Year Treasury ETF\">PST</a>, <a href=\"https://seekingalpha.com/symbol/TMF\" title=\"Direxion Daily 30-Year Treasury Bull 3x Shares ETF\">TMF</a>, <a href=\"https://seekingalpha.com/symbol/TTT\" title=\"ProShares UltraPro Short 20+ Year Treasury ETF\">TTT</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002745\" data-linked=\"Treasurys slip on concern Pimco may sour on U.S. debt\" data-tweet=\"$JNS $JNS $AZSEY - Treasurys slip on concern Pimco may sour on U.S. debt https://seekingalpha.com/news/2002745-treasurys-slip-on-concern-pimco-may-sour-on-u-s-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/2002745-treasurys-slip-on-concern-pimco-may-sour-on-u-s-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002735\" data-ts=\"1411740394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002735-solid-read-on-golden-week-bookings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid read on Golden Week bookings</a></h4><ul> <li>Golden Week bookings for Sands China in Macau <a href=\"http://www.bloomberg.com/news/2014-09-26/sands-china-jumps-as-it-sees-full-occupancy-over-holiday.html\" target=\"_blank\">look solid</a>, according to a company spokesperson.</li> <li>The development breaks a streak of negative data reads on traffic and sales for the gambling mecca.</li> <li>The national Golden Week holiday runs from October 1st to October 7th</li> <li>Macau stocks are in rally mode on the day: Melco Crown (MPEL) <font color='green'>+2.5%</font>, Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>) +<font color='green'>4.9%,</font> Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) <font color='green'>+2.9%</font>, SJM Holdings (<a href='https://seekingalpha.com/symbol/SJMHF' title='SJM Holdings Ltd.'>OTCPK:SJMHF</a>) <font color='green'>+4.1%</font>, Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) <font color='green'>+2.3%</font>, MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) <font color='green'>+2.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2002735\" data-linked=\"Solid read on Golden Week bookings\" data-tweet=\"$MLCO $MLCO $GXYEF - Solid read on Golden Week bookings https://seekingalpha.com/news/2002735-solid-read-on-golden-week-bookings?source=tweet\" data-url=\"https://seekingalpha.com/news/2002735-solid-read-on-golden-week-bookings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002715\" data-ts=\"1411740216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITB\" target=\"_blank\">LITB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002715-lightinthebox-plus-9_4-percent-on-q3-guidance-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LightInTheBox +9.4% on Q3 guidance hike</a></h4><ul>\n<li>LightInTheBox (NYSE:<a href=\"https://seekingalpha.com/symbol/LITB\" title=\"LightInTheBox Holding Co., Ltd.\">LITB</a>) now expects Q3 revenue of $94M-$96M (+38%-41% Y/Y), up from prior guidance of $92M-$94M and a $93.7M consensus.</li>\n<li>With shares down 30% YTD going into today, the guidance hike is being very well-received. They fell in August following LITB's Q2 report, as <a href=\"https://seekingalpha.com/news/1945275-lightinthebox-minus-8-percent-margin-worries-overshadow-top-line-strength\" target=\"_blank\">margin declines</a> overshadowed strong top-line numbers.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002715\" data-linked=\"LightInTheBox +9.4% on Q3 guidance hike\" data-tweet=\"$LITB - LightInTheBox +9.4% on Q3 guidance hike https://seekingalpha.com/news/2002715-lightinthebox-plus-9_4-percent-on-q3-guidance-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/2002715-lightinthebox-plus-9_4-percent-on-q3-guidance-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002655\" data-ts=\"1411739205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGLY\" target=\"_blank\">DGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002655-digital-ally-plus-30_9-percent-on-military-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Ally +30.9% on military order</a></h4><ul>\n<li>A U.S. military base has placed a $200K order for Digital Ally's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DGLY\" title=\"Digital Ally, Inc.\">DGLY</a>) video evidence-gathering system. The system includes DGLY's <a href=\"http://www.digitalallyinc.com/personal-camera.html\" target=\"_blank\">FirstVU HD</a> wearable camera, <a href=\"http://www.digitalallyinc.com/DVM-800-mobile-video.php\" target=\"_blank\">DVM-800</a> in-car camera, and <a href=\"http://www.marketwatch.com/story/digital-receives-vulinktm-patent-and-begins-shipping-new-product-to-law-enforcement-customers-2014-07-10\" target=\"_blank\">VuLink</a> hands-free recording activation tech.</li>\n<li>DGLY declares VuLink to be \"the only system that enables body cameras to start recording automatically and allows a department's in-car video systems to be automatically or manually activated simultaneously with the body cameras.\"</li>\n<li>Follow-on orders are expected. DGLY will \"attempt to deliver\" the initial order in Q3, but says product shortages may push out delivery to Q4.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002655\" data-linked=\"Digital Ally +30.9% on military order\" data-tweet=\"$DGLY - Digital Ally +30.9% on military order https://seekingalpha.com/news/2002655-digital-ally-plus-30_9-percent-on-military-order?source=tweet\" data-url=\"https://seekingalpha.com/news/2002655-digital-ally-plus-30_9-percent-on-military-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002555\" data-ts=\"1411737585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002555-zalviso-nda-resubmission-may-slip-beyond-q1-2015\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zalviso NDA resubmission may slip beyond Q1 2015</a></h4><ul>\n<li>AcelRx Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ACRX\" title=\"AcelRx Pharmaceuticals, Inc.\">ACRX</a>) says it is targeting its resubmission of the NDA for <a href=\"http://www.acelrx.com/pipeline/arx-01.html\" target=\"_blank\">Zalviso </a>(sufentanil sublingual tablet system) for Q1 2015. The timing could be delayed, however, depending on the timing of the FDA's review of its response to the CRL and feedback on the proposed bench testing and human factors study.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1871975-acelrx-gets-crl\" target=\"_blank\">The regulator issued the CRL</a> on July 25, 2014.</li>\n<li>ACRX is off <font color=\"red\">16%</font> premarket on moderately high volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002555\" data-linked=\"Zalviso NDA resubmission may slip beyond Q1 2015\" data-tweet=\"$ACRX - Zalviso NDA resubmission may slip beyond Q1 2015 https://seekingalpha.com/news/2002555-zalviso-nda-resubmission-may-slip-beyond-q1-2015?source=tweet\" data-url=\"https://seekingalpha.com/news/2002555-zalviso-nda-resubmission-may-slip-beyond-q1-2015\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002545\" data-ts=\"1411737553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALIZF\" target=\"_blank\">ALIZF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002545-allianz-slips-janus-capital-soars-off-of-gross-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allianz slips, Janus Capital soars off of Gross development</a></h4><ul> <li>Allianz (<a href=\"https://seekingalpha.com/symbol/ALIZF\" title=\"Allianz SE\">OTCPK:ALIZF</a>, <a href=\"https://seekingalpha.com/symbol/AZSEY\" title=\"Allianz SE ADR\">OTCPK:AZSEY</a>) slips in European action after Bill Gross <a href=\"https://seekingalpha.com/news/2002475-janus-capital-plus-19-percent-after-firm-hires-pimcos-bill-gross\" target=\"_blank\">bolts</a> from Pimco to Janus Capital.</li> <li>Shares of the financial services giant were <font color=\"red\">off 4.2%</font> in Frankfurt trading.</li> <li>The story is different at Janus Capital (NYSE:<a href=\"https://seekingalpha.com/symbol/JNS\" title=\"Janus Capital Group Inc.\">JNS</a>) with shares now <font color=\"green\">up 38.5%</font> premarket on the Gross development.</li> <li>Some analysts are waiting for the rest of the story to emerge on Gross' exit with the question on if a non-compete agreement exists being bandied around.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2002545\" data-linked=\"Allianz slips, Janus Capital soars off of Gross development\" data-tweet=\"$ALIZF $ALIZF $AZSEY - Allianz slips, Janus Capital soars off of Gross development https://seekingalpha.com/news/2002545-allianz-slips-janus-capital-soars-off-of-gross-development?source=tweet\" data-url=\"https://seekingalpha.com/news/2002545-allianz-slips-janus-capital-soars-off-of-gross-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002535\" data-ts=\"1411737294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002535-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/JNS\" title=\"Janus Capital Group Inc.\">JNS</a> <font color=\"green\">+37%</font>. <a href=\"https://seekingalpha.com/symbol/DGLY\" title=\"Digital Ally, Inc.\">DGLY</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/CNET\" title=\"ChinaNet Online Holdings, Inc.\">CNET</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"green\">+7%</font>. GALE <font color=\"green\">+7%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ACRX\" title=\"AcelRx Pharmaceuticals, Inc.\">ACRX</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/FINL\" title=\"The Finish Line, Inc.\">FINL</a> <font color=\"red\">-10%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002535\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$JNS $DGLY $RPRX - Premarket Gainers / Losers https://seekingalpha.com/news/2002535-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2002535-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002475\" data-ts=\"1411735418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNS\" target=\"_blank\">JNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002475-janus-capital-plus-19-percent-after-firm-hires-pimcos-bill-gross\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Janus Capital +19% after firm hires Pimco&#39;s Bill Gross</a></h4><ul>\n<li>\"Bond king\" Bill Gross is leaving Pimco, the company he helped found, to join Janus Capital (NYSE:<a href=\"https://seekingalpha.com/symbol/JNS\" title=\"Janus Capital Group Inc.\">JNS</a>) to manage a newly created Janus Global Unconstrained bond fund and related strategies.</li>\n<li>\"I chose Janus as my next home because of my long standing relationship with and respect for CEO Dick Weil and my desire to get back to spending the bulk of my day managing client assets,\" Gross says.</li>\n<li>JNS <font color=\"green\">+19.2%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002475\" data-linked=\"Janus Capital +19% after firm hires Pimco&#39;s Bill Gross\" data-tweet=\"$JNS - Janus Capital +19% after firm hires Pimco&#39;s Bill Gross https://seekingalpha.com/news/2002475-janus-capital-plus-19-percent-after-firm-hires-pimcos-bill-gross?source=tweet\" data-url=\"https://seekingalpha.com/news/2002475-janus-capital-plus-19-percent-after-firm-hires-pimcos-bill-gross\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002345\" data-ts=\"1411733366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPRX\" target=\"_blank\">RPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002345-androxal-superior-to-androgel-in-phase-3-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Androxal superior to Androgel in Phase 3 trial</a></h4><ul>\n<li>Shares of Repros Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a>) are up <font color=\"green\">12%</font> premarket on good volume in response to its report of positive results for oral <a href=\"http://reprosrx.com/androxal.php\" target=\"_blank\">Androxal </a>(clomiphene citrate) (NYSE:<a href=\"https://seekingalpha.com/symbol/ABBV\" title=\"AbbVie Inc.\">ABBV</a>) versus topical <a href=\"http://www.androgel.com/\" target=\"_blank\">Androgel </a>(testosterone gel) in a Phase 3 trial.</li>\n<li>In the study, ZA-304, Androxal met its co-primary efficacy endpoints while demonstrating results consistent with an earlier trial. Androxal was superior to Androgel in the percent change from baseline in average sperm concentration and percent of subjects considered to be responders. A responder is defined as a person achieving a 24-hour average testosterone in the normal range with associated average sperm concentration of 10 million/mL.</li>\n<li>The 129-patient study group was randomized into three cohorts, Androxal (41), Androgel (43) and placebo (45).</li>\n<li>The first primary efficacy endpoint was the percent change from baseline in sperm concentration. The median decrease in the Androxal cohort was 1% (stated as unchanged) compared to a median decrease of 71% in the Androgel cohort. The results were statistically significant compared to baseline and Androgel.</li>\n<li>The second primary efficacy endpoint was a comparison of the proportion of responders. The Androxal cohort demonstrated a success rate of 61% (25/41) compared to 16% (7/43) for Androgel. Again, the results were statistically significant.</li>\n<li>The company has a pre-IND meeting scheduled with the FDA for mid-November. It expects to file by year end. If approved, it will be the first drug therapy specifically targeting <a href=\"http://www.uptodate.com/contents/causes-of-secondary-hypogonadism-in-males\" target=\"_blank\">secondary hypogonadism</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2002345\" data-linked=\"Androxal superior to Androgel in Phase 3 trial\" data-tweet=\"$RPRX $RPRX $ABBV - Androxal superior to Androgel in Phase 3 trial https://seekingalpha.com/news/2002345-androxal-superior-to-androgel-in-phase-3-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/2002345-androxal-superior-to-androgel-in-phase-3-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2002205\" data-ts=\"1411729416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2002205-analysts-gush-over-strong-results-at-nike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts gush over strong results at Nike</a></h4><ul> <li>Janney lifts Nike (NYSE:<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a>) to a Buy rating from Neutral after digesting the athletic retailer's FQ1 report (<a href=\"https://seekingalpha.com/news/2001795-nike-beats-by-0_21-beats-on-revenue\" target=\"_blank\">earnings</a>, <a href=\"https://seekingalpha.com/news/2001875-nike-plus-4_9-percent-ah-futures-and-gross-margin-impress\" target=\"_blank\">details</a>, <a href=\"https://seekingalpha.com/news/2002005-nike-guides-above-consensus\" target=\"_blank\">guidance</a>).</li> <li>Citigroup says it's duly impressed by Nike's guidance. Shares are reiterated at Buy and the price target is taken to $93.</li> <li>Edward Jones analyst Brian Yarbrough <a href=\"http://www.theglobeandmail.com/report-on-business/international-business/us-business/nike-profit-tops-estimates-as-world-cup-gear-boosts-sales/article20794604/\" target=\"_blank\">notes</a> the strong results are more than a World Cup lift.</li>\n<li>\"The product is resonating with consumers. They are dominating and keep taking market share,\" says Yarbrough.</li> <li>NKE <font color=\"green\">+6.8%</font> premarket</li> </ul><div class=\"tiny-share-widget\" data-id=\"2002205\" data-linked=\"Analysts gush over strong results at Nike\" data-tweet=\"$NKE - Analysts gush over strong results at Nike https://seekingalpha.com/news/2002205-analysts-gush-over-strong-results-at-nike?source=tweet\" data-url=\"https://seekingalpha.com/news/2002205-analysts-gush-over-strong-results-at-nike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":35,"message":null,"success":true,"today":{"start":1576904400,"end":1576990799,"str":"Saturday, December 21, 2019"},"yesterday":{"start":1576818000,"end":1576904399}}